nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Hypoaesthesia—Etoposide—sarcoma	0.00357	0.00357	CcSEcCtD
Labetalol—Vision blurred—Mitoxantrone—sarcoma	0.00354	0.00354	CcSEcCtD
Labetalol—Oedema—Dactinomycin—sarcoma	0.00352	0.00352	CcSEcCtD
Labetalol—Blood urea increased—Doxorubicin—sarcoma	0.0035	0.0035	CcSEcCtD
Labetalol—Ill-defined disorder—Mitoxantrone—sarcoma	0.00348	0.00348	CcSEcCtD
Labetalol—Vertigo—Vincristine—sarcoma	0.00346	0.00346	CcSEcCtD
Labetalol—Dry eye—Doxorubicin—sarcoma	0.00342	0.00342	CcSEcCtD
Labetalol—Malaise—Mitoxantrone—sarcoma	0.00338	0.00338	CcSEcCtD
Labetalol—Flushing—Etoposide—sarcoma	0.00333	0.00333	CcSEcCtD
Labetalol—Hypertension—Vincristine—sarcoma	0.00333	0.00333	CcSEcCtD
Labetalol—Hypertension—Mitoxantrone—sarcoma	0.00324	0.00324	CcSEcCtD
Labetalol—Paraesthesia—Thiotepa—sarcoma	0.00318	0.00318	CcSEcCtD
Labetalol—Alopecia—Etoposide—sarcoma	0.00317	0.00317	CcSEcCtD
Labetalol—Discomfort—Mitoxantrone—sarcoma	0.00316	0.00316	CcSEcCtD
Labetalol—Somnolence—Thiotepa—sarcoma	0.00315	0.00315	CcSEcCtD
Labetalol—Anaphylactic shock—Vincristine—sarcoma	0.00314	0.00314	CcSEcCtD
Labetalol—Oedema—Vincristine—sarcoma	0.00314	0.00314	CcSEcCtD
Labetalol—Dyspepsia—Thiotepa—sarcoma	0.00312	0.00312	CcSEcCtD
Labetalol—Confusional state—Mitoxantrone—sarcoma	0.00309	0.00309	CcSEcCtD
Labetalol—Anaphylactic shock—Mitoxantrone—sarcoma	0.00306	0.00306	CcSEcCtD
Labetalol—Oedema—Mitoxantrone—sarcoma	0.00306	0.00306	CcSEcCtD
Labetalol—Fatigue—Thiotepa—sarcoma	0.00306	0.00306	CcSEcCtD
Labetalol—Hyperhidrosis—Vincristine—sarcoma	0.00304	0.00304	CcSEcCtD
Labetalol—Fatigue—Dactinomycin—sarcoma	0.00303	0.00303	CcSEcCtD
Labetalol—Pain—Thiotepa—sarcoma	0.00303	0.00303	CcSEcCtD
Labetalol—Constipation—Thiotepa—sarcoma	0.00303	0.00303	CcSEcCtD
Labetalol—Shock—Mitoxantrone—sarcoma	0.00301	0.00301	CcSEcCtD
Labetalol—Pain—Dactinomycin—sarcoma	0.00301	0.00301	CcSEcCtD
Labetalol—Anaphylactoid reaction—Epirubicin—sarcoma	0.003	0.003	CcSEcCtD
Labetalol—Muscle spasms—Etoposide—sarcoma	0.003	0.003	CcSEcCtD
Labetalol—Hypoglycaemia—Epirubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Labetalol—Cardiac failure—Epirubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Labetalol—Lethargy—Epirubicin—sarcoma	0.00297	0.00297	CcSEcCtD
Labetalol—Hyperhidrosis—Mitoxantrone—sarcoma	0.00296	0.00296	CcSEcCtD
Labetalol—Hypotension—Vincristine—sarcoma	0.00294	0.00294	CcSEcCtD
Labetalol—Feeling abnormal—Thiotepa—sarcoma	0.00292	0.00292	CcSEcCtD
Labetalol—Feeling abnormal—Dactinomycin—sarcoma	0.0029	0.0029	CcSEcCtD
Labetalol—Gastrointestinal pain—Thiotepa—sarcoma	0.0029	0.0029	CcSEcCtD
Labetalol—Ill-defined disorder—Etoposide—sarcoma	0.0029	0.0029	CcSEcCtD
Labetalol—Gastrointestinal pain—Dactinomycin—sarcoma	0.00288	0.00288	CcSEcCtD
Labetalol—Hypotension—Mitoxantrone—sarcoma	0.00286	0.00286	CcSEcCtD
Labetalol—Affect lability—Epirubicin—sarcoma	0.00286	0.00286	CcSEcCtD
Labetalol—Paraesthesia—Vincristine—sarcoma	0.00282	0.00282	CcSEcCtD
Labetalol—Urticaria—Thiotepa—sarcoma	0.00282	0.00282	CcSEcCtD
Labetalol—Malaise—Etoposide—sarcoma	0.00281	0.00281	CcSEcCtD
Labetalol—Vertigo—Etoposide—sarcoma	0.0028	0.0028	CcSEcCtD
Labetalol—Abdominal pain—Thiotepa—sarcoma	0.0028	0.0028	CcSEcCtD
Labetalol—Body temperature increased—Thiotepa—sarcoma	0.0028	0.0028	CcSEcCtD
Labetalol—Abdominal pain—Dactinomycin—sarcoma	0.00278	0.00278	CcSEcCtD
Labetalol—Body temperature increased—Dactinomycin—sarcoma	0.00278	0.00278	CcSEcCtD
Labetalol—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00278	0.00278	CcSEcCtD
Labetalol—Hypoglycaemia—Doxorubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Labetalol—Cardiac failure—Doxorubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Labetalol—Mood swings—Epirubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Labetalol—Paraesthesia—Mitoxantrone—sarcoma	0.00275	0.00275	CcSEcCtD
Labetalol—Loss of consciousness—Etoposide—sarcoma	0.00274	0.00274	CcSEcCtD
Labetalol—Lethargy—Doxorubicin—sarcoma	0.00274	0.00274	CcSEcCtD
Labetalol—Dyspnoea—Mitoxantrone—sarcoma	0.00273	0.00273	CcSEcCtD
Labetalol—Somnolence—Mitoxantrone—sarcoma	0.00272	0.00272	CcSEcCtD
Labetalol—Fatigue—Vincristine—sarcoma	0.00271	0.00271	CcSEcCtD
Labetalol—Dyspepsia—Mitoxantrone—sarcoma	0.0027	0.0027	CcSEcCtD
Labetalol—Hypertension—Etoposide—sarcoma	0.0027	0.0027	CcSEcCtD
Labetalol—Pain—Vincristine—sarcoma	0.00269	0.00269	CcSEcCtD
Labetalol—Constipation—Vincristine—sarcoma	0.00269	0.00269	CcSEcCtD
Labetalol—Liver function test abnormal—Epirubicin—sarcoma	0.00268	0.00268	CcSEcCtD
Labetalol—Orthostatic hypotension—Epirubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Labetalol—Abdominal pain upper—Epirubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Labetalol—Affect lability—Doxorubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Labetalol—Fatigue—Mitoxantrone—sarcoma	0.00264	0.00264	CcSEcCtD
Labetalol—Discomfort—Etoposide—sarcoma	0.00263	0.00263	CcSEcCtD
Labetalol—Pain—Mitoxantrone—sarcoma	0.00262	0.00262	CcSEcCtD
Labetalol—Constipation—Mitoxantrone—sarcoma	0.00262	0.00262	CcSEcCtD
Labetalol—Hypersensitivity—Thiotepa—sarcoma	0.00261	0.00261	CcSEcCtD
Labetalol—Hypersensitivity—Dactinomycin—sarcoma	0.00259	0.00259	CcSEcCtD
Labetalol—Gastrointestinal pain—Vincristine—sarcoma	0.00257	0.00257	CcSEcCtD
Labetalol—Confusional state—Etoposide—sarcoma	0.00257	0.00257	CcSEcCtD
Labetalol—Anaphylactic shock—Etoposide—sarcoma	0.00255	0.00255	CcSEcCtD
Labetalol—Mood swings—Doxorubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Labetalol—Asthenia—Thiotepa—sarcoma	0.00254	0.00254	CcSEcCtD
Labetalol—Asthenia—Dactinomycin—sarcoma	0.00253	0.00253	CcSEcCtD
Labetalol—Feeling abnormal—Mitoxantrone—sarcoma	0.00252	0.00252	CcSEcCtD
Labetalol—Pruritus—Thiotepa—sarcoma	0.00251	0.00251	CcSEcCtD
Labetalol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0025	0.0025	CcSEcCtD
Labetalol—Abdominal pain—Vincristine—sarcoma	0.00249	0.00249	CcSEcCtD
Labetalol—Body temperature increased—Vincristine—sarcoma	0.00249	0.00249	CcSEcCtD
Labetalol—Liver function test abnormal—Doxorubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Labetalol—Hyperhidrosis—Etoposide—sarcoma	0.00246	0.00246	CcSEcCtD
Labetalol—Orthostatic hypotension—Doxorubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Labetalol—Abdominal pain upper—Doxorubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Labetalol—Angina pectoris—Epirubicin—sarcoma	0.00245	0.00245	CcSEcCtD
Labetalol—Urticaria—Mitoxantrone—sarcoma	0.00243	0.00243	CcSEcCtD
Labetalol—Diarrhoea—Thiotepa—sarcoma	0.00243	0.00243	CcSEcCtD
Labetalol—Abdominal pain—Mitoxantrone—sarcoma	0.00242	0.00242	CcSEcCtD
Labetalol—Body temperature increased—Mitoxantrone—sarcoma	0.00242	0.00242	CcSEcCtD
Labetalol—Diarrhoea—Dactinomycin—sarcoma	0.00241	0.00241	CcSEcCtD
Labetalol—Hypotension—Etoposide—sarcoma	0.00238	0.00238	CcSEcCtD
Labetalol—Dysuria—Epirubicin—sarcoma	0.00235	0.00235	CcSEcCtD
Labetalol—Dizziness—Thiotepa—sarcoma	0.00235	0.00235	CcSEcCtD
Labetalol—Hypersensitivity—Vincristine—sarcoma	0.00232	0.00232	CcSEcCtD
Labetalol—Paraesthesia—Etoposide—sarcoma	0.00229	0.00229	CcSEcCtD
Labetalol—Dyspnoea—Etoposide—sarcoma	0.00227	0.00227	CcSEcCtD
Labetalol—Somnolence—Etoposide—sarcoma	0.00226	0.00226	CcSEcCtD
Labetalol—Angina pectoris—Doxorubicin—sarcoma	0.00226	0.00226	CcSEcCtD
Labetalol—Hypersensitivity—Mitoxantrone—sarcoma	0.00226	0.00226	CcSEcCtD
Labetalol—Asthenia—Vincristine—sarcoma	0.00226	0.00226	CcSEcCtD
Labetalol—Vomiting—Thiotepa—sarcoma	0.00226	0.00226	CcSEcCtD
Labetalol—Drowsiness—Epirubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Labetalol—Vomiting—Dactinomycin—sarcoma	0.00224	0.00224	CcSEcCtD
Labetalol—Rash—Thiotepa—sarcoma	0.00224	0.00224	CcSEcCtD
Labetalol—Dermatitis—Thiotepa—sarcoma	0.00223	0.00223	CcSEcCtD
Labetalol—Headache—Thiotepa—sarcoma	0.00222	0.00222	CcSEcCtD
Labetalol—Rash—Dactinomycin—sarcoma	0.00222	0.00222	CcSEcCtD
Labetalol—Asthenia—Mitoxantrone—sarcoma	0.0022	0.0022	CcSEcCtD
Labetalol—Fatigue—Etoposide—sarcoma	0.0022	0.0022	CcSEcCtD
Labetalol—Jaundice—Epirubicin—sarcoma	0.00218	0.00218	CcSEcCtD
Labetalol—Constipation—Etoposide—sarcoma	0.00218	0.00218	CcSEcCtD
Labetalol—Pain—Etoposide—sarcoma	0.00218	0.00218	CcSEcCtD
Labetalol—Dysuria—Doxorubicin—sarcoma	0.00217	0.00217	CcSEcCtD
Labetalol—Diarrhoea—Vincristine—sarcoma	0.00215	0.00215	CcSEcCtD
Labetalol—Sweating—Epirubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Labetalol—Epistaxis—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Labetalol—Nausea—Thiotepa—sarcoma	0.00211	0.00211	CcSEcCtD
Labetalol—Feeling abnormal—Etoposide—sarcoma	0.0021	0.0021	CcSEcCtD
Labetalol—Diarrhoea—Mitoxantrone—sarcoma	0.0021	0.0021	CcSEcCtD
Labetalol—Nausea—Dactinomycin—sarcoma	0.00209	0.00209	CcSEcCtD
Labetalol—Agranulocytosis—Epirubicin—sarcoma	0.00209	0.00209	CcSEcCtD
Labetalol—Gastrointestinal pain—Etoposide—sarcoma	0.00208	0.00208	CcSEcCtD
Labetalol—Dizziness—Vincristine—sarcoma	0.00208	0.00208	CcSEcCtD
Labetalol—Drowsiness—Doxorubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Labetalol—Bradycardia—Epirubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Labetalol—Urticaria—Etoposide—sarcoma	0.00202	0.00202	CcSEcCtD
Labetalol—Jaundice—Doxorubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Labetalol—Abdominal pain—Etoposide—sarcoma	0.00201	0.00201	CcSEcCtD
Labetalol—Body temperature increased—Etoposide—sarcoma	0.00201	0.00201	CcSEcCtD
Labetalol—Hepatitis—Epirubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Labetalol—Hypoaesthesia—Epirubicin—sarcoma	0.002	0.002	CcSEcCtD
Labetalol—Vomiting—Vincristine—sarcoma	0.002	0.002	CcSEcCtD
Labetalol—Sweating—Doxorubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Labetalol—Rash—Vincristine—sarcoma	0.00198	0.00198	CcSEcCtD
Labetalol—Dermatitis—Vincristine—sarcoma	0.00198	0.00198	CcSEcCtD
Labetalol—Oedema peripheral—Epirubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Labetalol—Headache—Vincristine—sarcoma	0.00197	0.00197	CcSEcCtD
Labetalol—Epistaxis—Doxorubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Labetalol—Vomiting—Mitoxantrone—sarcoma	0.00195	0.00195	CcSEcCtD
Labetalol—Visual impairment—Epirubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Labetalol—Agranulocytosis—Doxorubicin—sarcoma	0.00193	0.00193	CcSEcCtD
Labetalol—Rash—Mitoxantrone—sarcoma	0.00193	0.00193	CcSEcCtD
Labetalol—Dermatitis—Mitoxantrone—sarcoma	0.00193	0.00193	CcSEcCtD
Labetalol—Headache—Mitoxantrone—sarcoma	0.00192	0.00192	CcSEcCtD
Labetalol—Bradycardia—Doxorubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Labetalol—Hypersensitivity—Etoposide—sarcoma	0.00188	0.00188	CcSEcCtD
Labetalol—Nausea—Vincristine—sarcoma	0.00187	0.00187	CcSEcCtD
Labetalol—Flushing—Epirubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Labetalol—Hepatitis—Doxorubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Labetalol—Hypoaesthesia—Doxorubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Labetalol—Oedema peripheral—Doxorubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Labetalol—Asthenia—Etoposide—sarcoma	0.00183	0.00183	CcSEcCtD
Labetalol—Nausea—Mitoxantrone—sarcoma	0.00182	0.00182	CcSEcCtD
Labetalol—Pruritus—Etoposide—sarcoma	0.0018	0.0018	CcSEcCtD
Labetalol—Visual impairment—Doxorubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Labetalol—Alopecia—Epirubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Labetalol—Mental disorder—Epirubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Labetalol—Erythema—Epirubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Labetalol—Diarrhoea—Etoposide—sarcoma	0.00174	0.00174	CcSEcCtD
Labetalol—Flushing—Doxorubicin—sarcoma	0.00173	0.00173	CcSEcCtD
Labetalol—Dizziness—Etoposide—sarcoma	0.00168	0.00168	CcSEcCtD
Labetalol—Muscle spasms—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Labetalol—Vision blurred—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Labetalol—Alopecia—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Labetalol—Mental disorder—Doxorubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Labetalol—Ill-defined disorder—Epirubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Labetalol—Vomiting—Etoposide—sarcoma	0.00162	0.00162	CcSEcCtD
Labetalol—Erythema—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Labetalol—Rash—Etoposide—sarcoma	0.00161	0.00161	CcSEcCtD
Labetalol—Dermatitis—Etoposide—sarcoma	0.0016	0.0016	CcSEcCtD
Labetalol—Headache—Etoposide—sarcoma	0.0016	0.0016	CcSEcCtD
Labetalol—Malaise—Epirubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Labetalol—Vertigo—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Labetalol—Syncope—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Labetalol—Muscle spasms—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Labetalol—Palpitations—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Labetalol—Loss of consciousness—Epirubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Labetalol—Vision blurred—Doxorubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Labetalol—Nausea—Etoposide—sarcoma	0.00151	0.00151	CcSEcCtD
Labetalol—Hypertension—Epirubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Labetalol—Ill-defined disorder—Doxorubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Labetalol—Discomfort—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Labetalol—Malaise—Doxorubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Labetalol—Vertigo—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Labetalol—Syncope—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Labetalol—Confusional state—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Labetalol—Palpitations—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Labetalol—Oedema—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Labetalol—Anaphylactic shock—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Labetalol—Loss of consciousness—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Labetalol—Shock—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Labetalol—Hypertension—Doxorubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Labetalol—Hyperhidrosis—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Labetalol—Discomfort—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Labetalol—Hypotension—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Labetalol—Confusional state—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Labetalol—Anaphylactic shock—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Labetalol—Oedema—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Labetalol—Shock—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Labetalol—Paraesthesia—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Labetalol—Hyperhidrosis—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Labetalol—Dyspnoea—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Labetalol—Somnolence—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Labetalol—Dyspepsia—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Labetalol—Hypotension—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Labetalol—Fatigue—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Labetalol—Pain—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Labetalol—Constipation—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Labetalol—Paraesthesia—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Labetalol—Dyspnoea—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Labetalol—Feeling abnormal—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Labetalol—Somnolence—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Labetalol—Gastrointestinal pain—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Labetalol—Dyspepsia—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Labetalol—Fatigue—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Labetalol—Urticaria—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Labetalol—Pain—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Labetalol—Constipation—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Labetalol—Abdominal pain—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Labetalol—Body temperature increased—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Labetalol—Feeling abnormal—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Labetalol—Gastrointestinal pain—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Labetalol—Hypersensitivity—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Labetalol—Urticaria—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Labetalol—Abdominal pain—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Labetalol—Body temperature increased—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Labetalol—Asthenia—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Labetalol—Pruritus—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Labetalol—Diarrhoea—Epirubicin—sarcoma	0.000977	0.000977	CcSEcCtD
Labetalol—Hypersensitivity—Doxorubicin—sarcoma	0.000974	0.000974	CcSEcCtD
Labetalol—Asthenia—Doxorubicin—sarcoma	0.000948	0.000948	CcSEcCtD
Labetalol—Dizziness—Epirubicin—sarcoma	0.000944	0.000944	CcSEcCtD
Labetalol—Pruritus—Doxorubicin—sarcoma	0.000935	0.000935	CcSEcCtD
Labetalol—Vomiting—Epirubicin—sarcoma	0.000908	0.000908	CcSEcCtD
Labetalol—Diarrhoea—Doxorubicin—sarcoma	0.000904	0.000904	CcSEcCtD
Labetalol—Rash—Epirubicin—sarcoma	0.0009	0.0009	CcSEcCtD
Labetalol—Dermatitis—Epirubicin—sarcoma	0.0009	0.0009	CcSEcCtD
Labetalol—Headache—Epirubicin—sarcoma	0.000895	0.000895	CcSEcCtD
Labetalol—Dizziness—Doxorubicin—sarcoma	0.000874	0.000874	CcSEcCtD
Labetalol—Nausea—Epirubicin—sarcoma	0.000848	0.000848	CcSEcCtD
Labetalol—Vomiting—Doxorubicin—sarcoma	0.00084	0.00084	CcSEcCtD
Labetalol—Rash—Doxorubicin—sarcoma	0.000833	0.000833	CcSEcCtD
Labetalol—Dermatitis—Doxorubicin—sarcoma	0.000832	0.000832	CcSEcCtD
Labetalol—Headache—Doxorubicin—sarcoma	0.000828	0.000828	CcSEcCtD
Labetalol—Nausea—Doxorubicin—sarcoma	0.000785	0.000785	CcSEcCtD
